Were currently exploring this within CalorieScience and would genuinely value perspectives from dietitians, nutritionists, obesity specialists, endocrinologists, and researchers
One product replaces multiple strength options and simplifies daily taurine supplementation
Overall, semaglutide and topiramate stand out as effective options for weight loss when compared to other medications
Our main finding is that LFD is associated with an increase in circulating GLP-1 levels in IBS patients
Their use in these populations has been associated with hemoglobin A1c reduction, significant weight loss, and a decrease in long-term microvascular and macrovascular complications ( This mini-review discusses clinical studies evaluating adjuvant treatment with GLP-1RA in patients with T1D as an opportunity to improve glycemic control, achieve weight loss, and decrease total daily insulin (TDI) requirements in these patients